Cost-effectiveness of Escitalopram vs. Venlafaxin XR in the treatment of major depressive disorder in Germany

被引：1
|
作者：
Kulp, W [1 ]
Greiner, W [1 ]
Schulenburg, JM [1 ]
机构：
[1] Univ Hannover, Hannover, Germany
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)63062-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：392 / 393
页数：2
相关论文
共 50 条
  • [11] Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany
    Kulp W.
    Graf Von Der Schulenburg J.-M.
    Greiner W.
    The European Journal of Health Economics, 2005, 6 (4) : 317 - 321
  • [12] Cost-effectiveness of duloxetine vs. venlafaxine XR and SSRIS in patients with major depressive disorder in primary and secondary care in Spain
    De Cock, E.
    Benedict, A.
    Le, T. K.
    Sacristin del Castillo, J. A.
    Dilla, T.
    VALUE IN HEALTH, 2007, 10 (06) : A295 - A296
  • [13] Venlafaxine XR versus escitalopram treatment of major depressive disorder
    Zarra, J
    Schmidt, L
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S394 - S395
  • [14] Escitalopram versus venlafaxine XR in the treatment of major depressive disorder
    Montgomery, S.
    Andersen, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S233 - S233
  • [15] Cost-Effectiveness Evaluation in Sweden of Escitalopram Compared with Venlafaxine in Major Depressive Disorder
    Despiegel, Nicolas
    Marteau, Florence
    Danchenko, Natalya
    Linne, Agneta Bjorck
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 : S12 - S12
  • [16] Cost-Effectiveness of Escitalopram in Major Depressive Disorder in the Dutch Health Care Setting
    Nuijten, Mark J. C.
    Brignone, Melanie
    Marteau, Florence
    den Boer, Johan A.
    Hoencamp, Erik
    CLINICAL THERAPEUTICS, 2012, 34 (06) : 1364 - 1378
  • [17] Cost-effectiveness of escitalopram versus citalopram in outpatients suffering from major depressive disorder
    Fantino, B.
    Moore, N.
    VALUE IN HEALTH, 2006, 9 (06) : A313 - A313
  • [18] Cost-effectiveness of brexpiprazole adjunctive treatment for major depressive disorder
    Sussman, Matthew
    Yu, Jeffrey
    Kamat, Siddhesh A.
    Hartry, Ann
    Legacy, Susan
    Duffy, Ruth
    Aigbogun, Myrlene Sanon
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 207 : 54 - 62
  • [19] Algorithms For Treatment of Major Depressive Disorder: Efficacy and Cost-Effectiveness
    Bauer, Michael
    Rush, A. John
    Ricken, Roland
    Pilhatsch, Maximilian
    Adli, Mazda
    PHARMACOPSYCHIATRY, 2019, 52 (03) : 117 - 125
  • [20] The cost-effectiveness of paroxetine in treatment of major depressive disorder in Japan
    Nakahara, N
    Kamae, I
    Yanagisawa, S
    VALUE IN HEALTH, 2004, 7 (06) : 780 - 780
12345